Title: Decentralized Clinical Trials – Real Solutions in Real-Time
Date: Tuesday, June 21st, 2022
Time: 10:20 a.m. – 10:50 a.m. CDT
Location: Exhibit Hall Theater #2
During this Innovation Theater, we’ll poll the audience and explore how you feel about pressing issues and timely DCT topics. Our expert panel includes Jen Horonjeff (Founder/CEO, Savvy Cooperative), Craig Lipset (Co-Chair, DTRA), Bryan McDowell (VP, eCOA Clinical Science, Clario), and moderator Matt McCarty (CMO, Clario). The panel will provide technology, science, and patient perspectives throughout the discussion and offer you real DCT solutions in real-time.
Advisor and Founder at Clinical Innovation Partners
Craig Lipset is Founder and Managing Partner of Clinical Innovation Partners, a growth advisory practice for clinical trial innovation. He is Co-Chair of the Decentralized Trials & Research Alliance, Assistant Professor of Health Informatics at Rutgers University, and adjunct faculty at the University of Rochester Center for Health and Technology. Craig serves on the Board of Directors for the MedStar Health Research Institute, Foundation for Sarcoidosis Research, and for Circuit Clinical. He is a Venture Partner with Boston Millennia Partners. Craig is a past DIA Annual Meeting Chair, and currently serves on the Regional Advisory Committee for North America.
Co-Founder & CEO at Savvy Cooperative
Jen Horonjeff, PhD, is a patient advocate and the founder & CEO of Savvy Cooperative, the first and only patient-owned co-op that helps innovators connect directly with diverse patients in order to get the insights they need to build better and more inclusive healthcare solutions. Jen was named one of the 50 Most Daring Entrepreneurs of 2018 by Entrepreneur Magazine, alongside the likes of Elon Musk, Chance the Rapper and Reese Witherspoon for her innovative patient engagement model at Savvy. She grew up with multiple autoimmune conditions and survived a brain tumor as an adult, and prior to starting Savvy was a patient-centered outcomes researcher, human factors engineer, human-centered designer, and an FDA advisor. Utilizing her unique perspective, Jen strives to give patients a platform to have their experiences be heard, included, and equitably valued–because the future of healthcare is co-designed with patients.
Chief Strategy and Marketing Officer at Clario
As Chief Strategy and Marketing Officer at Clario, Matt leads the enterprise’s strategic direction and marketing capabilities. Matt has spent the last 15 years in various executive leadership roles at leading clinical research and commercial healthcare organizations. Most recently, Matt spearheaded the launch of Clario. His work has focused on high-impact product launches (such as Avastin & Herceptin), bringing innovative technology solutions to market, and accelerating the industry-wide adoption of decentralized trials. Matt implemented ICON’s global patient engagement function and served as the first Head of Direct-to-Patient Research (Virtual Trials / DCT) at IQVIA. Prior to that, Matt founded a technology marketing company that was acquired, where he then served as Head of Sales & Marketing.
VP, eCOA Science & Consulting at Clario
In his role as VP, eCOA Science & Consulting, Bryan brings extensive experience and expertise to achieve smarter drug development, clinical trial design and execution (including decentralized and remote trials) to vastly expand the reach and access of trials to more patients, provide improved patient experience and data quality to deliver accelerated drug & device development programs. Bryan is a thought leader and recognized strategist & visionary and continues to influence, drive and deliver on the pharma wide industry necessity for smarter drug & device development and life cycle management.
Title: BYOD VS. Provisioned Devices: A Cross-Study Exploration of Factors Influencing Patient Compliance
Date: Tuesday, June 21st, 2022
Time: 12:00 p.m. – 1:15 p.m. CDT
Location: Level 3 F2 Entrance
Patients’ ability to submit Patient Reported Outcomes (ePRO) using their own smartphones (BYOD) has the potential to reduce burden and has expanded the reach of hybrid and decentralized trials. Impact on patient compliance is not well understood. The poster presentation discusses the method, results and conclusion of a retrospective analysis of compliance for eCOA on provisioned and BYOD modalities using data collected from 2018-2021.
Principal Scientific Advisor at Clario
Dr. Hughes is a scientist with over 15 years of experience in behavioral and life sciences, focusing particularly on the role of human behavior in optimizing health outcomes through prevention, care, and treatment. She is currently a Principal Scientific Advisor at Clario, a global data and technology company that helps to minimize risk in clinical trials. She provides dedicated support to a number of pharmaceutical company sponsors and is the subject matter expert for vaccines and infectious diseases. She has taught courses at the CDC, USAID, and has held international workshops on these issues in more than a dozen countries.